Search Results 331-340 of 13385 for Modafinil

1. Drugs and Supplements that Start with A - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “A” to learn about drug side effects, proper use and ...

2. Midostaurin And Decitabine In Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia And FLT3 Mutation - Mayo Clinic

   Phenobarbital. Moderate inducers of CYP3A4/5; 50-80% decrease in AUC. Bosentan (Tracleer®); Efavirenz (Sustiva®); Etravirine (Intelence®); Modafinil (Provigil®) ...

3. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

   ... modafinil, phenobarbital, phenytoin, rifabutin, rifampin, pioglitazone, or St. John wort) or strong inhibitors of CYP3A4 (indinavir, nelfinavir, ritonavir ...

4. A Long-Term Safety Study Of JZP-110 In The Treatment Of Excessive Sleepiness In Subjects With Narcolepsy Or OSA - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. How do antiviral drugs work?

   Antiviral drugs are medicines that fight against viruses in your body by impeding the infection process. Antivirals are commonly used to treat HIV/AIDS, ...

6. Ketamine Associated ACC GABA and Glutamate Change and Depression Remission - Mayo Clinic

   CYP3A4 inducers carbamazepine and modafinil are prohibited within two weeks prior to administration of study drug and at least 24 hours after last dose of study ...

7. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors - Mayo Clinic

   ... modafinil, phenobarbital, phenytoin, pioglitazone, rifabutin, rifampin, St. John's wort); use of the aforementioned inducers is prohibited ≤ 7 days prior ...

8. CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography for Risk Stratification - Mayo Clinic

   The purpose of this research study is to determine if carotid artery ultrasound scanning can provide additional information for determining cardiovascular risk ...

9. A Phase II, Multicenter Study Of The EZH2 Inhibitor Tazemetostat In Adult Subjects With INI1-Negative Tumors Or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

   A Phase II, Multicenter Study Of The EZH2 Inhibitor Tazemetostat In Adult Subjects With INI1-Negative Tumors Or Relapsed/Refractory Synovial Sarcoma · Share ...

10. Diethylpropion (oral route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...